Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Neurol ; 24(2): 357-365, 2017 02.
Article in English | MEDLINE | ID: mdl-27982501

ABSTRACT

BACKGROUND AND PURPOSE: To determine whether iron deposition in deep brain nuclei assessed using high-pass filtered phase imaging plays a role in motor disease severity in Parkinson's disease (PD). METHODS: Seventy patients with mild to moderate PD and 20 age- and gender-matched healthy volunteers (HVs) underwent susceptibility-weighted imaging on a 3 T magnetic resonance imaging scanner. Phase shifts (radians) in deep brain nuclei were derived from high-pass filtered phase images and compared between groups. Analysis of clinical laterality and correlations with motor severity (Unified Parkinson's Disease Rating Scale, Part III, UPDRS-III) were performed. Phase shifts (in radians) were compared between HVs and three PD subgroups divided according to UPDRS-III scores using analysis of covariance, adjusting for age and regional area. RESULTS: Parkinson's disease patients had significantly (P < 0.001) higher radians than HVs bilaterally in the putamen, globus pallidus and substantia nigra (SN). The SN contralateral to the most affected side showed higher radians (P < 0.001) compared to the less affected side. SN radians positively correlated with UPDRS-III and bradykinesia-rigidity subscores, but not with tremor subscores. ancova followed by post hoc Bonferroni-adjusted pairwise comparisons revealed that SN radians were significantly greater in the PD subgroup with higher UPDRS-III scores compared to both lowest UPDRS-III PD and HV groups (P < 0.001). CONCLUSIONS: Increased nigral iron accumulation in PD appears to be stratified according to disease motor severity and correlates with symptoms related to dopaminergic neurodegeneration. This semi-quantitative in vivo iron assessment could prove useful for objectively monitoring PD progression, especially in clinical trials concerning iron chelation therapies.


Subject(s)
Gray Matter/metabolism , Iron/metabolism , Movement Disorders/physiopathology , Parkinson Disease/metabolism , Parkinson Disease/physiopathology , Adult , Aged , Cross-Sectional Studies , Disease Susceptibility , Female , Gray Matter/diagnostic imaging , Humans , Hypokinesia/etiology , Hypokinesia/physiopathology , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Male , Middle Aged , Movement Disorders/etiology , Muscle Rigidity/etiology , Muscle Rigidity/physiopathology , Parkinson Disease/complications , Parkinson Disease/diagnostic imaging , Substantia Nigra/diagnostic imaging , Substantia Nigra/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...